Carcinoma: all 6,719 studies

Page 2 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.

• Metastatic Nasopharyngeal CarcinomaRecruitingNCT06886347Phase 1
• An Exploratory Clinical Study on Neoadjuvant Treatment of Hepatocellular Carcinoma with QL1706 Combined with LenvatinibNot yet recruitingNCT06884982Phase 2
• A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.RecruitingNCT06883539Phase 1
• Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational StudyRecruitingNCT06879964
• Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCCRecruitingNCT06876844Phase 2
• Regional Lymph Node Metastasis and Survival Outcomes in Advanced HCCRecruitingNCT06876753
• Holmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular CarcinomaRecruitingNCT06873269
• Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals TherapyNot yet recruitingNCT06872047
• Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver DiseaseNot yet recruitingNCT06871930
• Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk AreasRecruitingNCT06870435Not applicable
• A Clinical Research of CD70-targeted CAR-NKT Cells (CGC738) Therapy in RCCNot yet recruitingNCT06870279Phase 1
• Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.RecruitingNCT06869473Phase 2
• TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell CancerRecruitingNCT06868433Phase 1
• Efficacy and Safety of Yttrium-90 Microspheres Selective Internal Radiotherapy Combined with Immune Checkpoint Inhibitors and Anti-angiogenesis Drugs Sequential HAIC for Hepatocellular CarcinomaNot yet recruitingNCT06867432Phase 2
• Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular CarcinomaRecruitingNCT06864221
• Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid CarcinomasRecruitingNCT06863805
• Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCCNot yet recruitingNCT06861894Phase 2
• Total Neoadjuvant Therapy Combined With Adebrelimab in Locally Advanced Resectable ESCCNot yet recruitingNCT06861777Phase 2/3
• Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal CancerNot yet recruitingNCT06861712Phase 2
• Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort StudyRecruitingNCT06861114
• Heterogeneity of Oral Squamous Cell Carcinoma Analysis by Single Cell RNA SequencingNot yet recruitingNCT06861036Not applicable
• QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Resectable Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06852456Phase 2
• PET-TC in Thyroid EvaluationEnrolling by invitationNCT06852144
• GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.RecruitingNCT06851247Phase 2
• Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid CarcinomaNot yet recruitingNCT06848920Phase 2
• SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian CancerNot yet recruitingNCT06846424Phase 1
• A Phase II Study of Toripalimab Combined With Sequential Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06843889Phase 2
• Exercise Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)Not yet recruitingNCT06839014Not applicable
• Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal VaricesNot yet recruitingNCT06836778Not applicable
• Sialic Acid in Hepatocellular CarcinomaNot yet recruitingNCT06836518
• A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsRecruitingNCT06835569Phase 1
• Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary CarcinomaRecruitingNCT06833229
• Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical CarcinomaRecruitingNCT06831175Phase 2
• A Deep Learning Model for Diagnosing Lymph Node Metastasis in Nasopharyngeal Carcinoma(NPC)RecruitingNCT06829147
• Towards Cure Via Only Ultra-short ICB in CSCCRecruitingNCT06823479Phase 2
• 9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial CarcinomaRecruitingNCT06823427Phase 2
• A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAICNot yet recruitingNCT06823050
• Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)RecruitingNCT06821958Not applicable
• Validation of TAD in HER-2 with More Than 2 Lymph NodesEnrolling by invitationNCT06821490
• Reconstruction of Cervical Lymphatic System During Head and Neck Squamous Cell Carcinoma SurgeryNot yet recruitingNCT06815705Not applicable
• Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06814067Phase 2
• Prognostic Factors for HCC and Liver Transplantation in Patients with MASLD/MASHRecruitingNCT06813508
• Using Tumor Models to Determine TreatmentsRecruitingNCT06813079Phase 2
• HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of RecurrenceRecruitingNCT06812039Phase 2
• Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the CervixEnrolling by invitationNCT06810895
• Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)RecruitingNCT06806930Phase 2
• Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular CarcinomaRecruitingNCT06806579
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyRecruitingNCT06805812
• The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration StudyRecruitingNCT06801977
• HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort StudyNot yet recruitingNCT06798246
• Fusing Ultrasound and Magnetic Resonance Imaging to Intelligently Plan Highly Conformal Ablation Thermal Field for Hepatocellular CarcinomaNot yet recruitingNCT06798194
• Hypofractionated Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT06796270Not applicable
• Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular CarcinomaRecruitingNCT06788353
• Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic CancerRecruitingNCT06782932Phase 1/2
• A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal CarcinomaNot yet recruitingNCT06781112Phase 2
• A Clinical Trial Assessing the Safety and Efficacy of Biodegradable Magnesium Embolic Microspheres for Primary Hepatocellular CarcinomaNot yet recruitingNCT06779461Phase 3
• Liver and Spleen Stiffness to Predict the Presence of Esaphageal Varices in Cirrhotic with Advanced HCCEnrolling by invitationNCT06773260
• Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.Not yet recruitingNCT06772428Phase 3
• Hypofractionated Radiotherapy for HNSCC in Elderly PatientsEnrolling by invitationNCT06768125Not applicable
• Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines TreatmentRecruitingNCT06766266Phase 1
• Prognostic Value of TIL in Nasopharyngeal CarcinomaEnrolling by invitationNCT06763640
• Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After SurgeryRecruitingNCT06762782Phase 2
• Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNCT06759155Phase 2
• This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.RecruitingNCT06758401Phase 3
• Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCCRecruitingNCT06752798Phase 2
• KSD-101 Therapy for Standard Treatment Failed EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical TrialNot yet recruitingNCT06752473Early Phase 1
• Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPCNot yet recruitingNCT06752382Phase 2
• Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPCRecruitingNCT06752239Phase 3
• Monitoring Salivary Gland Injury in Nasopharyngeal Carcinoma Patients After Radiotherapy Using Multi-Modal RadiomicsNot yet recruitingNCT06751381
• 89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP StudyRecruitingNCT06750419Phase 3
• The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular CarcinomaNot yet recruitingNCT06750159
• Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract CarcinomaRecruitingNCT06749730Phase 2
• Effect of Prehabilitation During the Conversion Therapy on Postoperative Outcomes in Unresectable Hepatocellular CarcinomaNot yet recruitingNCT06749678Not applicable
• Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs TherapyNot yet recruitingNCT06746961Phase 1/2
• The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor TherapyRecruitingNCT06746194
• Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and NeckRecruitingNCT06744296
• A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard TherapyRecruitingNCT06742892Phase 2
• PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCCRecruitingNCT06742424Phase 2
• Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular CarcinomaRecruitingNCT06741020Phase 1/2
• SBRT Combined with Camrelizumab and Apatinib for Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma.Not yet recruitingNCT06739317Phase 2/3
• ChemoRT With and Without Dental Stent for Taste Protection in NPC PatientsRecruitingNCT06733948Phase 2
• Clinicopathological Features of Renal Cell Carcinoma in Young PatientsNot yet recruitingNCT06730997
• Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell CarcinomaNot yet recruitingNCT06728618Phase 2
• The Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCCRecruitingNCT06727162
• Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid CarcinomaNot yet recruitingNCT06725628
• Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid CarcinomaRecruitingNCT06725576
• Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before TransplantRecruitingNCT06725121Phase 1/2
• Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell CarcinomaEnrolling by invitationNCT06715501Not applicable
• Trilaciclib in Preventing Hematopoietic Suppression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaNot yet recruitingNCT06714266Phase 2
• Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in ChinaEnrolling by invitationNCT06712017
• Tumor Regression Grade As Predictor of Adjuvant TherapyRecruitingNCT06710665
• A Phase II Clinical Study of Sintilimab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) (NICE-CS)RecruitingNCT06709417Phase 2
• Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular CarcinomaNot yet recruitingNCT06708650Not applicable
• Y-90 SIRT for Unresectable HCC Larger Than 7cmRecruitingNCT06707233Phase 2
• Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCCNot yet recruitingNCT06699498Phase 2
• Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTCNot yet recruitingNCT06699459Phase 2
• Treatment with Intensity Modulated Radiotherapy on the Change of Cognitive Function in Nasopharyngeal Carcinoma Patients: a Prospective Cohort StudyNot yet recruitingNCT06695936
• Intravascular Radiofrequency Ablation of Sympathetic Nerves for the Treatment of Hepatocellular CarcinomaRecruitingNCT06694636Not applicable
• Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCCNot yet recruitingNCT06694350Phase 2
• An Adjuvant Study to Evaluate SMS001 (Paclitaxel) in Non-Small Cell Lung CancerRecruitingNCT06693336Phase 2

← Carcinoma overview